Jay Venkatesan Insider Trading $XCUR EXICURE, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jay Venkatesan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jay Venkatesan. Jay Venkatesan is Director in Targanta Therapeutics Corp. ($TARG) and Director in Lion Biotechnologies, Inc. ($LBIO) and See Remarks in Angion Biomedica Corp. ($ANG) and Director in ALPINE IMMUNE SCIENCES, INC. ($ALPN) and President in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Max-1 Acquisition Corp ($XCUR).
Jay Venkatesan in EXICURE, INC.
Trading Symbol: XCURIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jay Venkatesan: Director
Holdings: 311,544 shares
Latest Transaction: Jul 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jay Venkatesan in EXICURE, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ANG, XCUR, IOVA, TARG
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | M | 1.03 | 12,930 | 13,318 | 0 | |
Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | M | 0.65 | 9,310 | 6,052 | 0 | |
Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Buy | M | 1.03 | 12,930 | 13,318 | 324,473 | 311.5 K to 324.5 K (+4.15 %) |
Jul 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Buy | M | 0.65 | 9,310 | 6,052 | 311,544 | 302.2 K to 311.5 K (+3.08 %) |
Jun 08 2020 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | A | 2.79 | 21,693 | 60,523 | 21,693 | |
Aug 06 2019 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Buy | P | 2.00 | 250,000 | 500,000 | 302,234 | 52.2 K to 302.2 K (+478.62 %) |
Jun 14 2019 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | A | 2.78 | 21,693 | 60,307 | 21,693 | |
Jun 21 2018 | XCUR | EXICURE, INC. | Venkatesan Jay | Director | Option Exercise | A | 5.82 | 21,693 | 126,253 | 21,693 | |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Option Exercise | A | 4.21 | 24,824 | 104,509 | 24,824 | |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Option Exercise | A | 1.03 | 12,929 | 13,317 | 12,929 | |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Option Exercise | A | 0.65 | 9,309 | 6,051 | 9,309 | |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Buy | P | 3.00 | 66,666 | 199,998 | 156,858 | 90.2 K to 156.9 K (+73.92 %) |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Grant | A | 0.00 | 52,234 | 0 | 52,234 | 0 to 52.2 K |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Buy | J | 0.00 | 90,192 | 0 | 90,192 | 0 to 90.2 K |
Sep 28 2017 | XCUR | Max-1 Acquisition ... | Venkatesan Jay | Director | Buy | J | 0.00 | 190,957 | 0 | 190,957 | 0 to 191 K |
Page: 1